Hiroaki Ueno
Director Ejecutivo en MITSUBISHI TANABE PHARMA CORPORATION .
Origen de la red de primer grado Hiroaki Ueno.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Other | 31 | |
The Kaiteki Institute, Inc.
 The Kaiteki Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Kaiteki Institute, Inc. engages in the research and investigation of social trends. It also involves in the research and development of new enterprises and operation and management of contract research. The company was founded on April 1, 2009 and is headquartered in Tokyo, Japan.
7
| Subsidiary | Miscellaneous Commercial Services | 7 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Hiroaki Ueno a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Medicago, Inc.
 Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Biotechnology | Director/Board Member Director/Board Member | |
| TOKYO ELECTRIC POWER COMPANY HOLDINGS, INC. | Electric Utilities | Chairman | |
| TOSHIBA | Semiconductors | Director/Board Member | |
| MIZUHO FINANCIAL GROUP, INC. | Major Banks | Director/Board Member | |
| THE KANSAI ELECTRIC POWER CO., INC. | Electric Utilities | President | |
| TOHOKU ELECTRIC POWER COMPANY, INCORPORATED | Alternative Power Generation | Director/Board Member | |
| OSAKA GAS COMPANY., LTD. | Gas Distributors | Comptroller/Controller/Auditor Director/Board Member | |
Mitsubishi Chemical Corp.
 Mitsubishi Chemical Corp. Chemicals: Major DiversifiedProcess Industries Mitsubishi Chemical Corp. engages in the manufacture and sale of performance products and industrial materials. Its products and materials are used in automobiles and aircrafts; packaging, labels and films; IT, electronics and displays; environment and energy; and medical, food and bio products. The company was founded on August 31, 1933 and is headquartered in Tokyo, Japan. | Chemicals: Major Diversified | President Director/Board Member Chief Executive Officer Comptroller/Controller/Auditor Director/Board Member | |
| KEIHAN HOLDINGS CO., LTD. | Railroads | Chairman Director/Board Member | |
| NIPPON SANSO HOLDINGS CORPORATION | Chemicals: Specialty | Chairman Chief Executive Officer Director/Board Member | |
| SAPPORO HOLDINGS LIMITED | Beverages: Alcoholic | Director/Board Member Chief Executive Officer | |
| SANTEN PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| SHIMADZU CORPORATION | Medical Specialties | Chairman | |
| IMPERIAL HOTEL, LTD. | Hotels/Resorts/Cruise lines | Director/Board Member | |
| DAI-DAN CO., LTD. | Engineering & Construction | Director/Board Member | |
| TOHO HOLDINGS CO., LTD. | Medical Distributors | Director/Board Member | |
Nippon Telegraph & Telephone West Corp.
 Nippon Telegraph & Telephone West Corp. Specialty TelecommunicationsCommunications Nippon Telegraph & Telephone West Corp. provides regional telecommunication services in the western parts of Japan. The firm's activities include telephone services, integrated digital communications services, leased circuit services and other telecommunication-related activities. The company was founded on July 1, 1999 and is headquartered in Osaka, Japan. | Specialty Telecommunications | President | |
| Keio University | College/University | Undergraduate Degree | |
| Osaka University | College/University | Undergraduate Degree Doctorate Degree | |
| MITSUBISHI CHEMICAL GROUP CORPORATION | Chemicals: Major Diversified | President Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member Corporate Officer/Principal President Director/Board Member Director/Board Member Director/Board Member Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer | |
API Corp.
 API Corp. Pharmaceuticals: MajorHealth Technology API Corp. engages in the manufacture and sale of drug substances, pharmaceutical formulation intermediates, investigational drug manufacturing and others. The company was founded in 2002 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member | |
| University of Tokyo | College/University | Graduate Degree Graduate Degree Doctorate Degree Undergraduate Degree | |
| Kobe University | College/University | Masters Business Admin Masters Business Admin | |
| Kyoto University | College/University | Undergraduate Degree Graduate Degree | |
| Kanazawa University | College/University | Undergraduate Degree | |
Japan Nuclear Fuel Ltd.
 Japan Nuclear Fuel Ltd. Chemicals: SpecialtyProcess Industries Japan Nuclear Fuel Ltd. produces inorganic chemicals. The frim offers uranium enrichment, reprocessing of spent nuclear fuel, temporary storage of nuclear fuel materials and wastes returned from overseas reprocessing plant, disposal of low-level radioactive wastes and MOX fuel fabrication services. The company was founded on March 1, 1980 and is headquartered in , Japan. | Chemicals: Specialty | Chairman | |
| Japan Association of Corporate Executives | Chairman | ||
Santen, Inc.
 Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Medical Specialties | Chief Executive Officer | |
| NEURODERM LTD | Biotechnology | Chairman Director/Board Member | |
SanBio, Inc.
 SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Medical/Nursing Services | Chief Executive Officer | |
| Osaka Prefecture University | College/University | Doctorate Degree | |
MP Healthcare Venture Management, Inc.
 MP Healthcare Venture Management, Inc. Investment ManagersFinance MP Healthcare Venture Management, Inc (MP Healthcare Venture) is a venture capital subsidiary of Mitsubishi Tanabe Pharma Corp founded in 2006. The firm is headquartered in Boston, Massachusetts. | Investment Managers | President Private Equity Investor Director/Board Member | |
Mitsubishi Chemical Media Co., Ltd.
 Mitsubishi Chemical Media Co., Ltd. Computer PeripheralsElectronic Technology Part of Mitsubishi Chemical Group Corp., Mitsubishi Chemical Media Co., Ltd. sends information to enrich people's lives. The company is based in Tokyo, Japan. The text in the company's description is in Japanese and translates to "We send information to enrich your life. Thank you, Earth." | Computer Peripherals | President | |
MCC PTA India Corp. Pvt Ltd.
 MCC PTA India Corp. Pvt Ltd. Chemicals: SpecialtyProcess Industries MCC PTA India Corp. Pvt Ltd. manufactures and sells purified terephthalic acid. The company was founded in 1997 and is headquartered in New Delhi, India. | Chemicals: Specialty | Director/Board Member | |
Nippon Asahan Aluminium Co., Ltd.
 Nippon Asahan Aluminium Co., Ltd. AluminumNon-Energy Minerals Nippon Asahan Aluminium Co., Ltd. is a Japanese investment company that focuses on aluminum production and smelting. The private company is based in Tokyo, Japan. | Aluminum | Director/Board Member | |
| Mitsubishi Chemical Group Sci & Tech Research Center, Inc. | Chief Executive Officer | ||
Mitsubishi Tanabe Pharma Factory Ltd.
 Mitsubishi Tanabe Pharma Factory Ltd. Pharmaceuticals: MajorHealth Technology Part of Mitsubishi Chemical Group Corp., Mitsubishi Tanabe Pharma Factory Ltd. is a pharmaceutical company based in Osaka, Japan. The Japanese company produces integrated production from raw drugs to pharmaceuticals, designed preparation, and clinical trial drug manufacturing. The company supports diverse human resources through the enhancement of the compatible support system between life events and work, the introduction of a flexible working system, and work on work style reform and diversity initiatives. The company also promotes environmental safety management and management that is friendly to the earth. | Pharmaceuticals: Major | President | |
| Yoshitomiyakuhin Corp. | President | ||
| JAPAN DISPLAY INC. | Electronic Components | Director/Board Member | |
Mitsubishi Chemical Holdings America, Inc.
 Mitsubishi Chemical Holdings America, Inc. Chemicals: Major DiversifiedProcess Industries Part of Mitsubishi Chemical Group Corp., Mitsubishi Chemical Holdings America, Inc. is a company that manufactures and supplies chemical products. The company is based in New York, NY. | Chemicals: Major Diversified | Chief Executive Officer | |
| SANBIO COMPANY LIMITED | Pharmaceuticals: Major | Chief Operating Officer | |
Mitsubishi Tanabe Pharma Holdings America, Inc.
 Mitsubishi Tanabe Pharma Holdings America, Inc. Pharmaceuticals: OtherHealth Technology Part of Mitsubishi Chemical Group Corp., Mitsubishi Tanabe Pharma Holdings America, Inc. manufactures and distributes pharmaceuticals, pet products & medicines. The company is based in Jersey City, NJ. | Pharmaceuticals: Other | President | |
Mitsubishi Tanabe Pharma America, Inc.
 Mitsubishi Tanabe Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Part of Mitsubishi Chemical Group Corp., Mitsubishi Tanabe Pharma America, Inc. (MTPA) is a pharmaceutical company based in Jersey City, NJ. MTPA is a wholly-owned subsidiary of Mitsubishi Tanabe Pharma Corporation (MTPC) and was established to develop and advance their pipeline as well as commercialize approved pharmaceutical products in the United States. MTPA delivers innovative solutions that are guided by patients' unmet medical needs. | Pharmaceuticals: Major | President |
Estadísticas
Internacional
| Japón | 40 |
| Estados Unidos | 7 |
| Canadá | 3 |
| Israel | 2 |
| India | 2 |
Sectorial
| Health Technology | 12 |
| Process Industries | 11 |
| Consumer Services | 9 |
| Utilities | 5 |
| Electronic Technology | 4 |
Operativa
| Director/Board Member | 90 |
| Corporate Officer/Principal | 29 |
| President | 26 |
| Independent Dir/Board Member | 19 |
| Chairman | 15 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Hiroaki Ueno
- Conexiones Empresas
